Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Blood

• Publication date

  2004-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2004-03-1190PMID 15328153
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities

  2004cited by this paper
• CpG-A-Induced Monocyte IFN-γ-Inducible Protein-10 Production Is Regulated by Plasmacytoid Dendritic Cell-Derived IFN-α1

  2003cited by this paper
• IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells

  2003cited by this paper
• IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro.

  2003cited by this paper
• Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

  2003cited by this paper
• Intratumor CpG-Oligodeoxynucleotide Injection Induces Protective Antitumor T Cell Immunity 1

  2003cited by this paper
• IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells1

  2003cited by this paper
• Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer

  2003cited by this paper
• CpG motifs: the active ingredient in bacterial extracts?

  2003cited by this paper
• Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

  2003cited by this paper
• CpG-A Oligonucleotides Induce a Monocyte-Derived Dendritic Cell-Like Phenotype That Preferentially Activates CD8 T Cells1

  2003cited by this paper
• Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence

  2003cited by this paper
• CpG-A-induced monocyte IFN-gamma-inducible protein-10 production is regulated by plasmacytoid dendritic cell-derived IFN-alpha.

  2003cited by this paper
• Interleukin 15 Controls both Proliferation and Survival of a Subset of Memory-Phenotype CD8+ T Cells

  2002cited by this paper
• Bacterial CpG-DNA licenses TLR9.

  2002cited by this paper
• Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution.

  2002cited by this paper
• Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines.

  2002cited by this paper
• Interleukin-2 and interleukin-15: immunotherapy for cancer.

  2002cited by this paper
• Interleukin-15 and the regulation of lymphoid homeostasis.

  2002cited by this paper
• New biologic agents for the treatment of cutaneous T-cell lymphoma.

  2002cited by this paper
• Type I interferons produced by dendritic cells promote their phenotypic and functional activation.

  2002cited by this paper
• CpG motifs in bacterial DNA and their immune effects.

  2002cited by this paper
• CpG Are Efficient Adjuvants for Specific CTL Induction Against Tumor Antigen-Derived Peptide

  2002cited by this paper
• Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.

  2002cited by this paper
• Plasmacytoid dendritic cells: the key to CpG.

  2002cited by this paper
• Toll-like receptors: critical proteins linking innate and acquired immunity

  2001cited by this paper
• Cytokine-driven Proliferation and Differentiation of Human Naive, Central Memory, and Effector Memory CD4+ T Cells

  2001cited by this paper
• Interleukin 15: biology and relevance to human disease.

  2001cited by this paper
• Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

  2001cited by this paper
• Cutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex1

  2001cited by this paper
• Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.

  2001cited by this paper
• Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.

  2001cited by this paper
• Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.

  2001cited by this paper
• IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation1

  2001cited by this paper
• Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.

  2001cited by this paper
• Human natural killer cells : a unique innate immunoregulatory role for the CD 56 bright subset

  2001cited by this paper
• Increased interleukin 5 production in eosinophilic Sézary syndrome: regulation by interferon alfa and interleukin 12.

  2001cited by this paper
• Bacterial CpG-DNA Triggers Activation and Maturation of Human CD11c−, CD123+ Dendritic Cells1

  2001cited by this paper
• Type I interferon is required to mount an adaptive response to immunostimulatory DNA

  2001cited by this paper
• Identification of CpG oligonucleotide sequences with high induction of IFN‐α/β in plasmacytoid dendritic cells

  2001cited by this paper
• Toll‐like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL‐12

  2001cited by this paper
• Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset

  2001cited by this paper
• Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma.

  2000cited by this paper
• A Toll-like receptor recognizes bacterial DNA

  2000cited by this paper
• Bacterial CpG‐DNA activates dendritic cells in vivo: T helper cell‐independent cytotoxic T cell responses to soluble proteins

  2000cited by this paper
• IL‐15 and IL‐16 overexpression in cutaneous T‐cell lymphomas: stage‐dependent increase in mycosis fungoides progression

  2000cited by this paper
• CpG‐oligodeoxynucleotides enhance T‐cell receptor‐triggered interferon‐γ production and up‐regulation of CD69 via induction of antigen‐presenting cell‐derived interferon type I and interleukin‐12

  2000cited by this paper
• Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice

  2000cited by this paper
• Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization

  2000cited by this paper
• Presumptive Mediators of Growth Hormone Action on Insulin-Like Growth Factor I Release by Porcine Ovarian Granulosa Cells

  2000cited by this paper
• Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism

  2000cited by this paper
• CpG DNA Induces Maturation of Dendritic Cells with Distinct Effects on Nascent and Recycling MHC-II Antigen-Processing Mechanisms

  2000cited by this paper
• Photopheresis: clinical applications and mechanism of action.

  1999cited by this paper
• Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.

  1999cited by this paper
• CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.

  1999cited by this paper
• Type I Interferons Keep Activated T Cells Alive

  1999cited by this paper
• Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4.

  1999cited by this paper
• Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells.

  1998cited by this paper
• IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation.

  1998cited by this paper
• Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

  1998cited by this paper
• Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems

  1998cited by this paper
• Use of biological response modifiers in the treatment of cutaneous T-cell lymphoma.

  1998cited by this paper
• Type I Interferon-mediated Stimulation of T Cells by CpG DNA

  1998cited by this paper
• Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.

  1996cited by this paper
• Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells.

  1996cited by this paper
• Induction and regulation of IL-15 expression in murine macrophages.

  1996cited by this paper
• Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation.

  1996cited by this paper
• Mycosis fungoides and Sezary syndrome.

  1996cited by this paper
• Activation of naive and memory T cells by interleukin-15.

  1996cited by this paper
• IL-12 reverses cytokine and immune abnormalities in Sezary syndrome.

  1995cited by this paper
• The immunopathogenesis of cutaneous T-cell lymphoma.

  1995cited by this paper
• Expression of interleukin-4 and interleukin-5 mRNA in developing cutaneous late-phase reactions.

  1995cited by this paper
• Th2 cytokine profile in cutaneous T-cell lymphoma.

  1995cited by this paper
• Common cytokine receptor gamma chain (gamma c)-dependent cytokines: understanding in vivo functions by gene targeting.

  1995influential reference
• The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.

  1994cited by this paper
• Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma.

  1994cited by this paper
• Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.

  1994influential reference
• A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.

  1994cited by this paper
• Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

  1993cited by this paper
• The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cells.

  1993cited by this paper
• Immune responses in interleukin-2-deficient mice.

  1993cited by this paper
• Depressed lymphokine activated killer cell activity in mycosis fungoides. A possible marker for aggressive disease.

  1990cited by this paper
• The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.

  1986cited by this paper
• Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes

  1983cited by this paper
• Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes.

  1982cited by this paper
• Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.

  1981cited by this paper
• Cutaneous T cell lymphoma associated with recurrent panniculitis and reactive histiocytosis.

  1981cited by this paper
• Cutaneous T‐cell lymphoma

  1976cited by this paper

• Additional use of α-IgM antibodies potentiates CpG ODN2006-induced B cell activation by targeting mainly naïve and marginal zone-like B cells.

  2024cites this paper
• Simultaneous Stimulation of Peripheral Blood Mononuclear Cells with CpG ODN2006 and α-IgM Antibodies Leads to Strong Immune Responses in Monocytes Independent of B Cell Activation

  2024cites this paper
• The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets

  2024cites this paper
• Skin infiltrating NK cells in cutaneous T-cell lymphoma are increased in number and display phenotypic alterations partially driven by the tumor

  2023cites this paper
• Harnessing the immune system in the treatment of cutaneous T cell lymphomas

  2023cites this paper
• Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas

  2023cites this paper
• The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome

  2022cites this paper
• Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways.

  2021cites this paper
• A Novel CpG Oligodeoxynucleotide Enhanced the Therapeutic Effect of Epirubicin on Bladder Tumors in Rats

  2021cites this paper
• The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part I, Pathways and Targets for Immune Restoration and Tumor Eradication.

  2020cites this paper
• Real-world data on the effectiveness and safety of interferon-alpha-2a intralesional injection for the treatment of focally recalcitrant mycosis fungoides

  2020cites this paper
• Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma.

  2018influential citation
• Amendment history : Corrigendum ( March 2007 ) Immunopathogenesis and therapy of cutaneous T cell lymphoma

  2018influential citation
• T Cell Responses

  2018cites this paper
• Crotoxin from Crotalus durissus terrificus venom: In vitro cytotoxic activity of a heterodimeric phospholipase A2 on human cancer‐derived cell lines

  2018cites this paper
• Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management

  2017cites this paper
• Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome

  2017cites this paper
• United States Patent ( 10 ) Patent No . : US 8 , 124 , 084 B 2

  2017cites this paper
• Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover

  2016cites this paper
• CpG and Interleukin-15 Synergize to Enhance IFN-gamma Production by Activated CD 8 ( + ) T Cells

  2016cites this paper
• Correlation between mycosis fungoides and pregnancy

  2016cites this paper
• The Therapy of Cutaneous T Cell Lymphoma

  2016cites this paper
• Cutaneous T‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management

  2016cites this paper
• Positividade do imunomarcador FOXP3 em células T reguladoras em lesões de micose fungoide em fases clínicas iniciais e em dermatoses inflamatórias como fator auxiliar para o diagnóstico diferencial

  2015cites this paper
• The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.

  2015cites this paper
• Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics

  2015cites this paper
• CME Information: Cutaneous T-cell lymphoma: 2016 Update on diagnosis, risk-stratification, and management

  2015cites this paper
• Toll‐Like Receptors: Role in Inflammation and Cancer

  2014cites this paper
• CME Information: Cutaneous T-cell lymphoma: 2014 Update on diagnosis, risk-stratification, and management

  2014cites this paper
• Interleukin 12: still a promising candidate for tumor immunotherapy?

  2014influential citation
• Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and management

  2014cites this paper
• Toll-like receptors in lymphoid malignancies: double-edged sword.

  2014cites this paper
• IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF)

  2014influential citation
• Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.

  2014cites this paper
• dysregulation Staphylococcal enterotoxins stimulate lymphoma-associated immune

  2014cites this paper
• Acute myeloid leukemia: 2013 update on risk‐stratification and management

  2013cites this paper
• CD164 and FCRL3 are highly expressed on CD4+CD26-T cells in Sézary syndrome patients

  2013cites this paper
• Immunotherapy for Cutaneous T-Cell Lymphoma

  2013cites this paper
• Granulomatous slack skin disease: a review, in comparison with mycosis fungoides

  2012cites this paper
• CpG and Interleukin-15 Synergize to Enhance IFN-γ Production by Activated CD8+ T Cells

  2012influential citation
• The beauty of TLR agonists for CTCL.

  2012cites this paper
• Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome

  2012cites this paper
• Interleukin-15 in gene therapy of cancer.

  2012cites this paper
• Therapeutic Toll-like receptor agonists directly influence mouse and human T cell lymphoma cell viability and cytokine secretion

  2012cites this paper
• Actualités sur le syndrome de Sézary New developments in Sézary syndrome

  2012cites this paper
• [New developments in Sézary syndrome].

  2012cites this paper
• Dendritic cells and cutaneous T-cell lymphomas.

  2011cites this paper
• Just Accepted by Leukemia & Lymphoma Therapeutic TLR agonists directly influence mouse and human T cell lymphoma cell viability and cytokine secretion

  2011cites this paper
• Interleukin 15 as a promising candidate for tumor immunotherapy.

  2011cites this paper
• Immunogénicite de la mort cellulaire induite par les chimiothérapies anti-cancéreuses

  2011cites this paper
• Cutaneous T‐cell lymphoma: 2011 update on diagnosis, risk‐stratification, and management

  2011cites this paper
• Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).

  2011cites this paper
• primates Safety and immunologic effects of IL-15 administration in nonhuman

  2011cites this paper
• Actualités sur le syndrome de Sézary New developments in Sézary syndrome

  2011cites this paper
• Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma

  2011cites this paper
• Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression.

  2011cites this paper
• The role of natural killer cells in cancer therapy.

  2010cites this paper
• Important aspects of Toll-like receptors, ligands and their signaling pathways

  2010cites this paper
• Immunstimulatorische RNA-Oligonukleotide aktivieren T- und NK-Zellen über Toll-like-Rezeptor 7

  2010cites this paper
• Immune modulators as therapeutic agents for cutaneous T-cell lymphoma.

  2010cites this paper
• The Role of Toll-Like Receptors in Host Defenses and Their Relevance to Dermatologic Diseases

  2010cites this paper
• Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma.

  2010cites this paper
• Novel Human Interleukin-15 Agonists

  2009cites this paper
• Current developments with peptide-based human tumor vaccines

  2009cites this paper
• NKG2D ligands expression and NKG2D-mediated NK activity in Sezary patients.

  2009cites this paper
• Safety and immunologic effects of IL-15 administration in nonhuman primates.

  2009cites this paper
• Опыт лечения грибовидного микоза и синдрома Сезари в зависимости от стадий заболевания. Результаты собственных исследований и обзор литературы

  2009cites this paper
• Toll-like receptors and their role in hematologic malignancies.

  2009cites this paper
• Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA.

  2008cites this paper
• IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome.

  2008cites this paper
• CpG oligodeoxynucleotides as immunotherapy in cancer.

  2008cites this paper
• Toll-like receptors and their role in carcinogenesis and anti-tumor treatment

  2008cites this paper
• Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma

  2008cites this paper
• Herpes simplex virus type 1 dysregulates anti‐fungal defenses preventing monocyte activation and downregulating toll‐like receptor‐2

  2008cites this paper
• Mycosis fungoides.

  2008cites this paper
• Cutaneous T-cell lymphoma and emerging therapies

  2008cites this paper
• Role of toll-like receptors in regulatory functions of T and B cells

  2008cites this paper
• Toll-like receptor 9 (TLR9) agonists in the treatment of cancer

  2008cites this paper
• Mycosis fungoides and Sézary syndrome.

  2008cites this paper
• Gastric extranodal marginal zone B-cell lymphomas of MALT type exclusively express Toll-like receptor 4 in contrast to other lymphomas infiltrating the stomach.

  2008influential citation
• Cutaneous T-cell lymphoma: Biologic targets for therapy

  2007cites this paper
• Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas.

  2007cites this paper
• Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12.

  2007cites this paper
• Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN

  2007cites this paper
• Cell Subsets via IL-15 + Secretion in Human CD 8 γ Pathway of IFN-Profound Enhancement of the IL-12 / IL-18

  2007cites this paper
• Profound Enhancement of the IL-12/IL-18 Pathway of IFN-γ Secretion in Human CD8+ Memory T Cell Subsets via IL-151

  2007cites this paper
• Combined IL-15/IL-15Rα Immunotherapy Maximizes IL-15 Activity In Vivo1

  2006cites this paper
• Treatment of mycosis fungoides and Sézary syndrome: recent advances and novel therapies

  2006cites this paper
• Neues zur Molekularbiologie und zielgerichteten Therapie des kutanen T‐Zell Lymphoms

  2006cites this paper
• Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.

  2006cites this paper
• Primary cutaneous T-cell lymphomas.

  2006cites this paper
• Treatment of Mycosis Fungoides: Overview

  2006cites this paper
• New insights into the molecular biology and targeted therapy of cutaneous T‐cell lymphomas

  2006cites this paper
• Clinical and laboratory experience of vorinostat (suberoylanilide hydroxamic acid) in the treatment of cutaneous T-cell lymphoma

  2006cites this paper
• The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy

  2005cites this paper
• Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses.

  2005cites this paper
• Circulating natural killer lymphocytes are potential cytotoxic effectors against autologous malignant cells in sezary syndrome patients.

  2005cites this paper
• IL-15: targeting CD8+ T cells for immunotherapy.

  2005cites this paper
• Cutaneous T-cell lymphoma : molecular pathogenesis and clinical behaviour

  2005cites this paper
• Immunopathogenesis and therapy of cutaneous T cell lymphoma.

  2005influential citation